Regulatory Affairs Specialist

Prelude CorporationLaguna Hills, CA
11h$90,000 - $140,000

About The Position

JOB PURPOSE: · Execute on regulatory strategy of De Novo submissions for AI/ML-based Software as a Medical Device (SaMD) product, including AidaBreast. · Serve as regulatory lead for novel oncology diagnostic technologies integrating genomic and proteomic biomarkers. · Ensure alignment with FDA expectations for Breakthrough Device Designation (BDD), SaMD, and clinical validation requirements. · Collaborate cross-functionally to support development of clinically impactful breast cancer risk assessment tools. ESSENTIAL RESPONSIBILITIES: · Develop and execute regulatory strategies for De Novo and Breakthrough Device submissions. · Author and compile high-quality FDA submissions including device description, intended use, software documentation, and clinical evidence. · Lead FDA interactions including Q-Submissions, Pre-Subs, and deficiency responses. · Translate complex AI/ML algorithms and biomarker data into clear regulatory documentation. · Collaborate with Clinical, Biostatistics, Data Science, and Software teams on validation strategies. · Ensure alignment with QMS and regulatory standards (IEC 62304, ISO 14971). · Support regulatory positioning of prognostic and predictive oncology claims.

Requirements

  • 6+ years regulatory experience in medical devices or digital health.
  • Direct experience leading De Novo submissions (required).
  • Experience with SaMD and AI/ML-based algorithms strongly preferred.
  • Strong knowledge of FDA regulatory frameworks and guidance for SaMD.
  • Experience with clinical validation of diagnostic or predictive models.
  • Bachelor’s degree in science, engineering, or related field (advanced degree preferred).

Nice To Haves

  • Experience with oncology diagnostics or multi-omic assays.
  • Familiarity with CLIA/CAP laboratory environments.
  • Experience with Breakthrough Device Designation submissions.
  • RAC certification preferred.

Responsibilities

  • Develop and execute regulatory strategies for De Novo and Breakthrough Device submissions.
  • Author and compile high-quality FDA submissions including device description, intended use, software documentation, and clinical evidence.
  • Lead FDA interactions including Q-Submissions, Pre-Subs, and deficiency responses.
  • Translate complex AI/ML algorithms and biomarker data into clear regulatory documentation.
  • Collaborate with Clinical, Biostatistics, Data Science, and Software teams on validation strategies.
  • Ensure alignment with QMS and regulatory standards (IEC 62304, ISO 14971).
  • Support regulatory positioning of prognostic and predictive oncology claims.
© 2024 Teal Labs, Inc
Privacy PolicyTerms of Service